Omega Fund Management, LLC Buys Imago BioSciences Inc, Adagio Therapeutics Inc, Icosavax Inc, Sells Morphic Holding Inc, Atea Pharmaceuticals Inc

• New Purchases: IMGO, ADGI, ICVX,
• Added Positions: ALPN, SYRS,
• Reduced Positions: MORF, AVIR, REPL,

For the details of Omega Fund Management, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/omega+fund+management%2C+llc/current-portfolio/portfolio

1. Nuvation Bio Inc (NUVB) - 28,212,376 shares, 31.46% of the total portfolio.
2. Replimune Group Inc (REPL) - 4,896,074 shares, 16.28% of the total portfolio. Shares reduced by 2.24%
3. Kronos Bio Inc (KRON) - 3,818,283 shares, 8.98% of the total portfolio.
4. Morphic Holding Inc (MORF) - 1,315,952 shares, 8.36% of the total portfolio. Shares reduced by 25.54%
5. Imago BioSciences Inc (IMGO) - 3,018,737 shares, 6.78% of the total portfolio. New Position

Omega Fund Management, LLC initiated holding in Imago BioSciences Inc. The purchase prices were between $16 and $28.84, with an estimated average price of $21.56. The stock is now traded at around $22.890000. The impact to a portfolio due to this purchase was 6.78%. The holding were 3,018,737 shares as of 2021-09-30.

Omega Fund Management, LLC initiated holding in Adagio Therapeutics Inc. The purchase prices were between $20.88 and $56.08, with an estimated average price of $37.24. The stock is now traded at around $20.095000. The impact to a portfolio due to this purchase was 3%. The holding were 632,855 shares as of 2021-09-30.

Omega Fund Management, LLC initiated holding in Icosavax Inc. The purchase prices were between $24.85 and $40.25, with an estimated average price of $34.02. The stock is now traded at around $26.960000. The impact to a portfolio due to this purchase was 1.42%. The holding were 426,395 shares as of 2021-09-30.

Omega Fund Management, LLC added to a holding in Alpine Immune Sciences Inc by 57.96%. The purchase prices were between $8.19 and $11.31, with an estimated average price of $9.21. The stock is now traded at around $13.580000. The impact to a portfolio due to this purchase was 0.89%. The holding were 2,029,580 shares as of 2021-09-30.